학술논문

Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel
Document Type
Article
Source
In: Biochemical Pharmacology. (Biochemical Pharmacology, May 2024, 223)
Subject
Language
English
ISSN
18732968
00062952